Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Classical hematology 4Other hematologic neoplasm 3Lymphoid 2Plasma cell 1Myeloid 1CNS 1

Conditions

Leukemia, Myeloid, Acute 246Precursor Cell Lymphoblastic Leukemia-Lymphoma 147Myelodysplastic Syndromes 141Leukemia, Lymphocytic, Chronic, B-Cell 140Leukemia 128Lymphoma 80Hematologic Neoplasms 77Lymphoma, Non-Hodgkin 73Leukemia, Myelogenous, Chronic, BCR-ABL Positive 67Hodgkin Disease 55Multiple Myeloma 54Myeloproliferative Disorders 37Recurrence 34Lymphoma, Mantle-Cell 29Graft vs Host Disease 28Burkitt Lymphoma 28Lymphoma, B-Cell 26Lymphoma, Follicular 25Leukemia, Biphenotypic, Acute 25Anemia, Refractory, with Excess of Blasts 23Leukemia, Myelomonocytic, Chronic 22Lymphoma, Large B-Cell, Diffuse 21Neoplasms, Plasma Cell 20Lymphoma, B-Cell, Marginal Zone 20Primary Myelofibrosis 19Leukemia, Prolymphocytic 14Leukemia, Myeloid 13Anemia, Aplastic 13Neoplasms 12Leukemia, B-Cell 12

Interventions

fludarabine phosphate 4fludarabine 3Whole-Body Irradiation 3Thiotepa 3Melphalan 3Cyclophosphamide 3Therapeutics 2Busulfan 2Antilymphocyte Serum 2Alemtuzumab 2thymoglobulin 1fosphenytoin 1Vaccination 1Photopheresis 1Phenytoin 1Peripheral Blood Stem Cell Transplantation 1Injections 1Clofarabine 1Clinical Trials, Phase I as Topic 1Bone Marrow Transplantation 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Immunologic Deficiency Syndromes × fludarabine × Other hematologic neoplasm × Clear all
NCT01316549 2021-10-04

HCT

University of California, San Francisco

Completed
67 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

NCT03609814 2021-10-04

Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)

University of California, San Francisco

Completed
30 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

NCT00801931 2019-03-27

Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

Columbia University

Phase 1/2 Terminated
1 enrolled 8 charts
CNSClassical hematologyLymphoidOther hematologic neoplasm

Anemia, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡